CrossBeta Biosciences Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 10
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $10.4M
Latest Deal Amount

CrossBeta Biosciences General Information

Description

Developer of drug discovery and development platforms designed to generate stable oligomers. The company's drug discovery and development platforms offer discovery and development of multiple misfolded protein diseases, disease-specific antibodies, biomarker assays and oral treatment of Alzheimer's disease, enabling patients to avail quality drugs to recover from chronic diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Primary Office
  • Yalelaan 62
  • 3584 CM Utrecht
  • Netherlands
+31 030 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CrossBeta Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 30-Jan-2018 $10.4M 00.00 000.00 Completed Generating Revenue
4. Grant 18-Apr-2016 00000 00.00 Completed Generating Revenue
3. Later Stage VC 03-Mar-2013 00.00 Completed Generating Revenue
2. Grant 28-Aug-2011 $1.07M $2.7M Completed Generating Revenue
1. Early Stage VC 12-Apr-2010 $2.7M $2.7M Completed Startup
To view CrossBeta Biosciences’s complete valuation and funding history, request access »

CrossBeta Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of drug discovery and development platforms designed to generate stable oligomers. The company's drug discover
Drug Discovery
Utrecht, Netherlands
10 As of 2015
00.00
00.00 0000-00-00
000000&0 00.00

00000000

re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000

000000 0

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
0000000000000
Watertown, MA
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CrossBeta Biosciences Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000 00000000000 Formerly VC-backed Watertown, MA 00 00000 00000000 00000
0000000 0000000000 Venture Capital-Backed Bozeman, MT 000.00 0000000000 000.00
0000000 0000000000 Formerly Angel backed New York, NY 00 000.00 000000000 000.00
0000000 0000000000 Angel-Backed Madison, WI 0 00.00 00000000000 00.00
You’re viewing 5 of 12 competitors. Get the full list »

CrossBeta Biosciences Executive Team (6)

Name Title Board Seat Contact Info
Guus Scheefhals Chief Executive Officer
Marco de Beer Ph.D Chief Operating Officer
Martijn Gebbink Chief Scientific Officer & Co-Founder
Marcel Hoffmann Ph.D Interim Chief Scientific Officer
You’re viewing 4 of 6 executive team members. Get the full list »

CrossBeta Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CrossBeta Biosciences Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EuroTransBio Government 000 0000 000000 0
Michael J. Fox Foundation Limited Partner 000 0000 000000 0
Netherlands Enterprise Agency Government Minority 000 0000 000000 0
Rijksdienst voor Ondernemend Nederland Lender/Debt Provider 000 0000 000000 0
SenterNovem Corporation Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »